These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444 [TBL] [Abstract][Full Text] [Related]
4. A sensitive and quantitative assay for normal PrP in plasma. Gregori L; Gray BN; Rose E; Spinner DS; Kascsak RJ; Rohwer RG J Virol Methods; 2008 May; 149(2):251-9. PubMed ID: 18339433 [TBL] [Abstract][Full Text] [Related]
5. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE? Purdey M Med Hypotheses; 2000 Feb; 54(2):278-306. PubMed ID: 10790765 [TBL] [Abstract][Full Text] [Related]
6. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease. Herzog C; Rivière J; Lescoutra-Etchegaray N; Charbonnier A; Leblanc V; Salès N; Deslys JP; Lasmézas CI J Virol; 2005 Nov; 79(22):14339-45. PubMed ID: 16254368 [TBL] [Abstract][Full Text] [Related]
7. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy. Brown P Vox Sang; 2005 Aug; 89(2):63-70. PubMed ID: 16101685 [TBL] [Abstract][Full Text] [Related]
8. Generation of antibodies against bovine recombinant prion protein in various strains of mice. Andrievskaia O; McRae H; Elmgren C; Huang H; Balachandran A; Nielsen K Clin Vaccine Immunol; 2006 Jan; 13(1):98-105. PubMed ID: 16426006 [TBL] [Abstract][Full Text] [Related]
9. Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy. Trieschmann L; Navarrete Santos A; Kaschig K; Torkler S; Maas E; Schätzl H; Böhm G BMC Biotechnol; 2005 Oct; 5():26. PubMed ID: 16202155 [TBL] [Abstract][Full Text] [Related]
10. Detection of prion protein using a capillary electrophoresis-based competitive immunoassay with laser-induced fluorescence detection and cyclodextrin-aided separation. Yang WC; Yeung ES; Schmerr MJ Electrophoresis; 2005 May; 26(9):1751-9. PubMed ID: 15815999 [TBL] [Abstract][Full Text] [Related]
11. An overview of the diagnostic tools. Coste J Transfus Clin Biol; 2013 Sep; 20(4):412-5. PubMed ID: 23928182 [TBL] [Abstract][Full Text] [Related]
12. Are prions transported by plasma exosomes? Cervenakova L; Saá P; Yakovleva O; Vasilyeva I; de Castro J; Brown P; Dodd R Transfus Apher Sci; 2016 Aug; 55(1):70-83. PubMed ID: 27499183 [TBL] [Abstract][Full Text] [Related]
13. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions. Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058 [TBL] [Abstract][Full Text] [Related]
14. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases. Bastian FO; Fermin CD Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518 [TBL] [Abstract][Full Text] [Related]
15. Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease. Cervenakova L; Brown P; Soukharev S; Yakovleva O; Diringer H; Saenko EL; Drohan WN Electrophoresis; 2003 Mar; 24(5):853-9. PubMed ID: 12627447 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues. Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541 [TBL] [Abstract][Full Text] [Related]
17. TSE clearance during plasma products separation process by Gradiflow(TM). Wang K; Johnson A; Obradovic M; Anderson G; Maclean C; Nair H Biologicals; 2005 Jun; 33(2):87-94. PubMed ID: 15939286 [TBL] [Abstract][Full Text] [Related]
18. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples. Guntz P; Walter C; Schosseler P; Morel P; Coste J; Cazenave JP Transfusion; 2010 May; 50(5):989-95. PubMed ID: 20088835 [TBL] [Abstract][Full Text] [Related]
19. Simple and specific detection of abnormal prion protein by a magnetic bead-based immunoassay coupled with laser-induced fluorescence spectrofluorometry. Kim JI; Wang C; Kuizon S; Xu J; Barengolts D; Gray PC; Rubenstein R J Neuroimmunol; 2005 Jan; 158(1-2):112-9. PubMed ID: 15589044 [TBL] [Abstract][Full Text] [Related]
20. Current and future molecular diagnostics for prion diseases. Lehto MT; Peery HE; Cashman NR Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]